UBE2D1 is believed to play a role in DNA damage repair, with increased levels of IL-6 in the serum of HCC patients triggering the DNA damage response and genomic instability, resulting in the repeated amplification of UBE2D1 gene copies in the genome [30]. Here, UBE2D1 is linked to hepatocellular carcinoma.